These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35054365)

  • 21. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
    Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
    BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
    Yang Y; Chu FH; Xu WR; Sun JQ; Sun X; Ma XM; Yu MW; Yang GW; Wang XM
    Medicine (Baltimore); 2017 Nov; 96(47):e8487. PubMed ID: 29381923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways.
    Zhu L; Yan F; Wang Z; Dong H; Bian C; Wang T; Yu E; Li J
    Int J Cancer; 2018 Nov; 143(10):2488-2498. PubMed ID: 30183087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.
    Moon JW; Lee SK; Lee JO; Kim N; Lee YW; Kim SJ; Kang HJ; Kim J; Kim HS; Park SH
    J Exp Clin Cancer Res; 2014 Jan; 33(1):4. PubMed ID: 24393480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
    BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of
    Faltus C; Lahnsteiner A; Barrdahl M; Assenov Y; Hüsing A; Bogatyrova O; Laplana M; Johnson T; Muley T; Meister M; Warth A; Thomas M; Plass C; Kaaks R; Risch A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
    Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D
    BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers.
    Pekow J; Hernandez K; Meckel K; Deng Z; Haider HI; Khalil A; Zhang C; Talisila N; Siva S; Jasmine F; Li YC; Rubin DT; Hyman N; Bissonnette M; Weber C; Kibriya MG
    J Crohns Colitis; 2019 Jul; 13(7):884-893. PubMed ID: 30753380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.
    An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y
    Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.
    Hanley MP; Hahn MA; Li AX; Wu X; Lin J; Wang J; Choi AH; Ouyang Z; Fong Y; Pfeifer GP; Devers TJ; Rosenberg DW
    Oncogene; 2017 Aug; 36(35):5035-5044. PubMed ID: 28459462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide DNA methylation profiling of gastric cardia cancer.
    Lin R; Qian Y; Zhang J; Xia D; Guo D; Hong L; Qing B; Xu M; Huang Y; Lin W; Chen G; Liu S
    J Gastroenterol Hepatol; 2023 Feb; 38(2):290-300. PubMed ID: 36342849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
    Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
    Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.
    Simmer F; Brinkman AB; Assenov Y; Matarese F; Kaan A; Sabatino L; Villanueva A; Huertas D; Esteller M; Lengauer T; Bock C; Colantuoni V; Altucci L; Stunnenberg HG
    Epigenetics; 2012 Dec; 7(12):1355-67. PubMed ID: 23079744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylome in visceral adipose tissue can discriminate patients with and without colorectal cancer.
    Izquierdo AG; Boughanem H; Diaz-Lagares A; Arranz-Salas I; Esteller M; Tinahones FJ; Casanueva FF; Macias-Gonzalez M; Crujeiras AB
    Epigenetics; 2022 Jun; 17(6):665-676. PubMed ID: 34311674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
    Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
    Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
    Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.